Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian T Ruff

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Thrombosis and Haemostasis|September 13, 2020
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 TrialGiuseppe Boriani, Christian T Ruff, Julia F Kuder, et al.
Clinical Kidney Journal|October 23, 2024
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillationGunnar H Heine, Carolin Schneppe, Rupert Bauersachs, et al.
European Heart Journal|January 9, 2017
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialChristina L Fanola, Robert P Giugliano, Christian T Ruff, et al.
Circulation|April 15, 2024
Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"Rahul Aggarwal, Christian T Ruff, Saverio Virdone, et al.
Journal of the American Heart Association|September 2, 2017
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 TrialKaijun Wang, Haiyan Li, Winghan J Kwong, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain StudyMarc P Bonaca, Christian T Ruff, Joshua Kosowsky, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 16, 2020
Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trialsAnna Plitt, Thomas A Zelniker, Jeong-Gun Park, et al.
Hypertension (Dallas, Tex. : 1979)|July 30, 2019
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 TrialSungha Park, Brian A Bergmark, Minggao Shi, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 24, 2016
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic SubstudyDeepak K Gupta, Robert P Giugliano, Christian T Ruff, et al.
European Heart Journal|December 28, 2018
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trialTze-Fan Chao, Shih-Ann Chen, Christian T Ruff, et al.
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Thrombosis and Haemostasis|September 13, 2020
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 TrialGiuseppe Boriani, Christian T Ruff, Julia F Kuder, et al.
Clinical Kidney Journal|October 23, 2024
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillationGunnar H Heine, Carolin Schneppe, Rupert Bauersachs, et al.
European Heart Journal|January 9, 2017
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialChristina L Fanola, Robert P Giugliano, Christian T Ruff, et al.
Circulation|April 15, 2024
Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"Rahul Aggarwal, Christian T Ruff, Saverio Virdone, et al.
Journal of the American Heart Association|September 2, 2017
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 TrialKaijun Wang, Haiyan Li, Winghan J Kwong, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain StudyMarc P Bonaca, Christian T Ruff, Joshua Kosowsky, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 16, 2020
Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trialsAnna Plitt, Thomas A Zelniker, Jeong-Gun Park, et al.
Hypertension (Dallas, Tex. : 1979)|July 30, 2019
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 TrialSungha Park, Brian A Bergmark, Minggao Shi, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 24, 2016
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic SubstudyDeepak K Gupta, Robert P Giugliano, Christian T Ruff, et al.
European Heart Journal|December 28, 2018
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trialTze-Fan Chao, Shih-Ann Chen, Christian T Ruff, et al.
Pageof 20